Kumaravel; Gnanasambandam
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kumaravel; Gnanasambandam.The latest application filed is for "heteroaryl inhibitors of pad4".
Company Profile
21.64.73
- Kumaravel; Gnanasambandam - Cambridge MA
- Kumaravel; Gnanasambandam - Lexington MA
- KUMARAVEL; Gnanasambandam - Westford MA
- Kumaravel; Gnanasambandam - Westwood MA US
- Kumaravel; Gnanasambandam - North Andover MA
Patent Activity
| Patent | Date |
|---|---|
| IRAK4 inhibiting agents Grant 11,427,561 - Chan , et al. August 30, 2 | 2022-08-30 |
| Heteroaryl Inhibitors Of Pad4 App 20220081418 - Devraj; Rajesh ; et al. | 2022-03-17 |
| Heteroaryl inhibitors of PAD4 Grant 11,198,681 - Devraj , et al. December 14, 2 | 2021-12-14 |
| Heteroaryl Inhibitors Of Pad4 App 20210299115 - Devraj; Rajesh ; et al. | 2021-09-30 |
| Heteroaryl Inhibitors Of Pad4 App 20210188810 - Devraj; Rajesh ; et al. | 2021-06-24 |
| Irak4 Inhibiting Agents App 20210188809 - Chan; Timothy ; et al. | 2021-06-24 |
| Heteroaryl inhibitors of PAD4 Grant 11,026,937 - Devraj , et al. June 8, 2 | 2021-06-08 |
| Heterocyclic Compounds Useful As Pdk1 Inhibitors App 20210070752 - ARNDT; Joseph ; et al. | 2021-03-11 |
| S1P modulating agents Grant 10,894,040 - Thomas , et al. January 19, 2 | 2021-01-19 |
| Bruton's Tyrosine Kinase Inhibitors App 20200399283 - BUI; Minna ; et al. | 2020-12-24 |
| Biaryl inhibitors of Bruton'S tyrosine kinase Grant 10,759,783 - Hopkins , et al. Sep | 2020-09-01 |
| Covalent inhibitors of PAD4 Grant 10,703,741 - Beaumont , et al. | 2020-07-07 |
| IRAK4 inhibiting agents Grant 10,577,367 - Chan , et al. | 2020-03-03 |
| Bruton's tyrosine kinase inhibitors Grant 10,577,374 - Bui , et al. | 2020-03-03 |
| S1p Modulating Agents App 20200038385 - Thomas; Jermaine ; et al. | 2020-02-06 |
| Heteroaryl Inhibitors Of Pad4 App 20190358216 - Devraj; Rajesh ; et al. | 2019-11-28 |
| Covalent Inhibitors Of Pad4 App 20190276432 - Beaumont; Edward Jean ; et al. | 2019-09-12 |
| SIP modulating agents Grant 10,406,144 - Thomas , et al. Sept | 2019-09-10 |
| Nucleic Acid-binding Photoprobes And Uses Thereof App 20190270723 - Kumaravel; Gnanasambandam ; et al. | 2019-09-05 |
| Irak4 Inhibiting Agents App 20190248787 - Chan; Timothy ; et al. | 2019-08-15 |
| Biaryl Inhibitors Of Bruton's Tyrosine Kinase App 20190218204 - Hopkins; Brian T. ; et al. | 2019-07-18 |
| Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20190209592 - Thomas; Jermaine ; et al. | 2019-07-11 |
| Compounds And Methods For Modulating Rna Function App 20190194150 - Petter; Russell C. ; et al. | 2019-06-27 |
| Biaryl bruton's tyrosine kinase inhibitors Grant 10,280,169 - Hopkins , et al. | 2019-05-07 |
| Compounds that are S1P modulating agents and/or ATX modulating agents Grant 10,273,234 - Guckian , et al. | 2019-04-30 |
| Heterocyclic Compounds Useful As Pdk1 Inhibitors App 20190119268 - ARNDT; Joseph ; et al. | 2019-04-25 |
| IRAK4 inhibiting agents Grant 10,246,456 - Chan , et al. | 2019-04-02 |
| Bicyclic aryl sphingosine 1-phosphate analogs Grant 10,166,250 - Thomas , et al. J | 2019-01-01 |
| S1p Modulating Agents App 20180369215 - Thomas; Jermaine ; et al. | 2018-12-27 |
| ATX modulating agents Grant 10,144,732 - Kumaravel , et al. De | 2018-12-04 |
| Biaryl inhibitors of bruton's tyrosine kinase Grant 10,081,619 - Hopkins , et al. September 25, 2 | 2018-09-25 |
| Heterobicyclic sphingosine 1-phosphate analogs Grant 10,081,646 - Caldwell , et al. September 25, 2 | 2018-09-25 |
| S1P modulating agents Grant 10,034,869 - Thomas , et al. July 31, 2 | 2018-07-31 |
| Heterocyclic compounds useful as PDK1 inhibitors Grant 10,030,016 - Arndt , et al. July 24, 2 | 2018-07-24 |
| Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20180133233 - Thomas; Jermaine ; et al. | 2018-05-17 |
| Bicyclic inhibitors of PAD4 Grant 9,963,448 - Devraj , et al. May 8, 2 | 2018-05-08 |
| Compounds that are S1P modulating agents and/or ATX modulating agents Grant 9,944,666 - Guckian , et al. April 17, 2 | 2018-04-17 |
| Biaryl Inhibitors Of Bruton's Tyrosine Kinase App 20180093973 - Hopkins; Brian T. ; et al. | 2018-04-05 |
| Substituted pyrimidines for inhibiting Raf kinase activity Grant 9,920,048 - Chen , et al. March 20, 2 | 2018-03-20 |
| Bruton's Tyrosine Kinase Inhibitors App 20180065974 - BUI; Minna ; et al. | 2018-03-08 |
| S1p Modulating Agents App 20180028511 - Thomas; Jermaine ; et al. | 2018-02-01 |
| Heterobicyclic Sphingosine 1-phosphate Analogs App 20180002356 - Caldwell; Richard D. ; et al. | 2018-01-04 |
| S1P and/or ATX modulating agents Grant 9,850,206 - Peng , et al. December 26, 2 | 2017-12-26 |
| Bicyclic aryl sphingosine 1-phosphate analogs Grant 9,827,258 - Thomas , et al. November 28, 2 | 2017-11-28 |
| S1P modulating agents Grant 9,808,449 - Thomas , et al. November 7, 2 | 2017-11-07 |
| Biaryl inhibitors of Bruton's tyrosine kinase Grant 9,809,577 - Hopkins , et al. November 7, 2 | 2017-11-07 |
| Bruton's tyrosine kinase inhibitors Grant 9,790,229 - Bui , et al. October 17, 2 | 2017-10-17 |
| S1P and/or ATX modulating agents Grant 9,771,326 - Peng , et al. September 26, 2 | 2017-09-26 |
| S1P modulating agents Grant 9,765,016 - Guckian , et al. September 19, 2 | 2017-09-19 |
| Aza-benzimidazole inhibitors of PAD4 Grant 9,765,093 - Devraj , et al. September 19, 2 | 2017-09-19 |
| Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20170239280 - Thomas; Jermaine ; et al. | 2017-08-24 |
| Irak4 Inhibiting Agents App 20170204093 - Chan; Timothy ; et al. | 2017-07-20 |
| Heterobicyclic sphingosine 1-phosphate analogs Grant 9,708,353 - Caldwell , et al. July 18, 2 | 2017-07-18 |
| Atx Modulating Agents App 20170197960 - Kumaravel; Gnanasambandam ; et al. | 2017-07-13 |
| Compounds That Are S1p Modulating Agents And/or Atx Modulating Agents App 20170174710 - Guckian; Kevin M. ; et al. | 2017-06-22 |
| Aza-benzimidazole Inhibitors Of Pad4 App 20170166592 - Devraj; Rajesh ; et al. | 2017-06-15 |
| Bicyclic Inhibitors Of Pad4 App 20170166565 - Devraj; Rajesh ; et al. | 2017-06-15 |
| Compounds Useful as Raf Kinase Inhibitors App 20170158686 - CHEN; Weirong ; et al. | 2017-06-08 |
| Atx Modulating Agents App 20170158687 - Guckian; Kevin M. ; et al. | 2017-06-08 |
| Bicyclic aryl sphingosine 1-phosphate analogs Grant 9,572,824 - Thomas , et al. February 21, 2 | 2017-02-21 |
| ATX modulating agents Grant 9,555,050 - Guckian , et al. January 31, 2 | 2017-01-31 |
| Compounds that are S1P modulating agents and/or ATX modulating agents Grant 9,550,798 - Guckian , et al. January 24, 2 | 2017-01-24 |
| Heterocyclic compounds useful as PDK1 inhibitors Grant 9,546,165 - Arndt , et al. January 17, 2 | 2017-01-17 |
| Bruton's Tyrosine Kinase Inhibitors App 20160376281 - Bui; Minna ; et al. | 2016-12-29 |
| ATX modulating agents Grant 9,522,889 - Guckian , et al. December 20, 2 | 2016-12-20 |
| Compounds that are S1P modulating agents and/or ATX modulating agents Grant 9,499,485 - Guckian , et al. November 22, 2 | 2016-11-22 |
| Heterocyclic Compounds Useful As Pdk1 Inhibitors App 20160331756 - Arndt; Joseph ; et al. | 2016-11-17 |
| Biaryl Bruton's Tyrosine Kinase Inhibitors App 20160318935 - Hopkins; Brian T. ; et al. | 2016-11-03 |
| Biaryl Inhibitors Of Bruton's Tyrosine Kinase App 20160311802 - Hopkins; Brian T. ; et al. | 2016-10-27 |
| S1P modulating agents App 20160263093 - Thomas; Jermaine ; et al. | 2016-09-15 |
| S1P modulating agents Grant 9,340,527 - Thomas , et al. May 17, 2 | 2016-05-17 |
| Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20160129023 - Thomas; Jermaine ; et al. | 2016-05-12 |
| S1p And/or Atx Modulating Agents App 20160039825 - Peng; Hairuo ; et al. | 2016-02-11 |
| Bruton'S tyrosine kinase inhibitors Grant 9,249,146 - Bui , et al. February 2, 2 | 2016-02-02 |
| S1p Modulating Agents App 20150361029 - Guckian; Kevin ; et al. | 2015-12-17 |
| Bicyclic aryl sphingosine 1-phosphate analogs Grant 9,186,367 - Thomas , et al. November 17, 2 | 2015-11-17 |
| Heterobicyclic sphingosine 1-phosphate analogs Grant 9,181,191 - Caldwell , et al. November 10, 2 | 2015-11-10 |
| S1p And/or Atx Modulating Agents App 20150299123 - Peng; Hairuo ; et al. | 2015-10-22 |
| S1p And/or Atx Modulating Agents App 20150274663 - Peng; Hairuo ; et al. | 2015-10-01 |
| Atx Modulating Agents App 20150246063 - Guckian; Kevin ; et al. | 2015-09-03 |
| Heterobicyclic Sphingosine 1-phosphate Analogs App 20150232492 - Caldwell; Richard D. ; et al. | 2015-08-20 |
| Atx Modulating Agents App 20150210647 - Guckian; Kevin ; et al. | 2015-07-30 |
| Compounds That Are S1p Modulating Agents And/or Atx Modulating Agents App 20150203493 - Guckian; Kevin ; et al. | 2015-07-23 |
| Compounds That Are S1p Modulating Agents And/or Atx Modulating Agents App 20150203515 - Guckian; Kevin ; et al. | 2015-07-23 |
| Compounds That Are S1p Modulating Agents And/or Atx Modulating Agents App 20150183741 - Guckian; Kevin ; et al. | 2015-07-02 |
| Heteroaryl Btk inhibitors Grant 9,029,359 - Bui , et al. May 12, 2 | 2015-05-12 |
| S1P Modulating Agents App 20140371209 - Thomas; Jermaine ; et al. | 2014-12-18 |
| Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20140309190 - Thomas; Jermaine ; et al. | 2014-10-16 |
| Bruton's Tyrosine Kinase Inhibitors App 20140309212 - Bui; Minna ; et al. | 2014-10-16 |
| Bicyclic aryl sphingosine 1-phosphate analogs Grant 8,802,659 - Thomas , et al. August 12, 2 | 2014-08-12 |
| Compounds useful as Raf kinase inhibitors Grant 8,802,657 - Cossrow , et al. August 12, 2 | 2014-08-12 |
| Bruton's tyrosine kinase inhibitors Grant 8,785,440 - Bui , et al. July 22, 2 | 2014-07-22 |
| Bicyclic aryl sphingosine 1-phosphate analogs Grant 8,546,359 - Caldwell , et al. October 1, 2 | 2013-10-01 |
| Compounds Useful As Raf Kinase Inhibitors App 20130065858 - Chen; Weirong ; et al. | 2013-03-14 |
| Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20130059821 - Caldwell; Richard D. ; et al. | 2013-03-07 |
| Heterobicyclic sphingosine 1-phosphate analogs Grant 8,349,849 - Caldwell , et al. January 8, 2 | 2013-01-08 |
| Compounds useful as Raf kinase inhibitors Grant 8,293,752 - Chen , et al. October 23, 2 | 2012-10-23 |
| Bicyclic aryl sphingosine 1-phosphate analogs Grant 8,269,043 - Caldwell , et al. September 18, 2 | 2012-09-18 |
| Heterocyclic Compounds Useful As Pdk1 Inhibitors App 20120208819 - Arndt; Joseph ; et al. | 2012-08-16 |
| Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20120190649 - Thomas; Jermaine ; et al. | 2012-07-26 |
| Bruton's Tyrosine Kinase Inhibitors App 20120157443 - Bui; Minna ; et al. | 2012-06-21 |
| Heteroaryl Btk Inhibitors App 20120157442 - Bui; Minna ; et al. | 2012-06-21 |
| Heteroaryl Compounds Useful As Raf Kinase Inhibitors App 20120040951 - Chuaqui; Claudio ; et al. | 2012-02-16 |
| Heterocyclic compounds useful as RAF kinase inhibitors Grant 7,968,536 - Cossrow , et al. June 28, 2 | 2011-06-28 |
| A.sub.2a adenosine receptor antagonists Grant 7,834,014 - Peng , et al. November 16, 2 | 2010-11-16 |
| Bicyclic aryl sphingosine 1-phosphate analogs App 20100160258 - Caldwell; Richard D. ; et al. | 2010-06-24 |
| Heterobicyclic sphingosine 1-phosphate analogs App 20100160357 - Caldwell; Richard D. ; et al. | 2010-06-24 |
| Triazolopyrazines and methods of making and using the same Grant 7,674,791 - Dowling , et al. March 9, 2 | 2010-03-09 |
| Adenosine Receptor Antagonists And Methods Of Making And Using The Same App 20090221821 - Ensinger; Carol L. ; et al. | 2009-09-03 |
| Adenosine receptor antagonists and methods of making and using the same Grant 7,579,354 - Kiesman , et al. August 25, 2 | 2009-08-25 |
| Compounds Useful As Raf Kinase Inhibitors App 20090036419 - Chen; Weirong ; et al. | 2009-02-05 |
| Heterocyclic Compounds Useful as RAF Kinase Inhibitors App 20090005359 - Cossrow; Jennifer ; et al. | 2009-01-01 |
| Adenosine Receptor Antagonists And Methods Of Making And Using The Same App 20080004293 - Ensinger; Carol L. ; et al. | 2008-01-03 |
| Triazolotriazines and pyrazolotriazines and methods of making and using the same Grant 7,285,550 - Vu , et al. October 23, 2 | 2007-10-23 |
| A2a adenosine receptor antagonists App 20070173505 - Peng; Hairuo ; et al. | 2007-07-26 |
| Adenosine receptor antagonists and methods of making and using the same App 20070015732 - Kiesman; William F. ; et al. | 2007-01-18 |
| Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosine receptor antagonists App 20070010522 - Vu; Chi ; et al. | 2007-01-11 |
| Triazolopyrazines and methods of making and using the same App 20070010520 - Dowling; JamesE ; et al. | 2007-01-11 |
| Adenosine receptor antagonists and methods of making and using the same App 20060252730 - Kiesman; William F. ; et al. | 2006-11-09 |
| Adenosine receptor antagonists and methods of making and using the same App 20050222179 - Ensinger, Carol L. ; et al. | 2005-10-06 |
| Adenosine receptor antagonists and methods of making and using the same App 20040067966 - Kiesman, William F. ; et al. | 2004-04-08 |
| Adenosine receptor antagonists and methods of making and using the same App 20030225038 - Ensinger, Carol L. ; et al. | 2003-12-04 |
| Adenosine receptor antagonists and methods of making and using the same Grant 6,649,600 - Kiesman , et al. November 18, 2 | 2003-11-18 |
| Adenosine receptor antagonists and methods of making and using the same Grant 6,605,600 - Ensinger , et al. August 12, 2 | 2003-08-12 |
| Antimicrobial agents uses and compositions related thereto Grant 6,207,679 - Cuny , et al. March 27, 2 | 2001-03-27 |
| Quinoline-indole antimicrobial agents, uses and compositions related thereto Grant 6,172,084 - Cuny , et al. January 9, 2 | 2001-01-09 |
| Quinoline-indole antimicrobial agents, uses and compositions related thereto Grant 6,103,905 - Cuny , et al. August 15, 2 | 2000-08-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 